Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report

MIRACA LIFE SCIENCES

via BROWN RUDNICK LLP

2nd Quarter (Apr 1 - June 30) · 2013Posted Jul 18, 2013Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: MIRACA LIFE SCIENCES
Description: Healthcare
Location: Texas · United States of America

Registrant

Firm: BROWN RUDNICK LLP
Description: Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Issues related to anatomic pathology and the "in-office ancillary" services exception to the Ethics in Patient Referrals Act.
LobbyistsHENRY W MENN iii · LISA LAYMAN
Covered position (HENRY W MENN iii): Min SD & Counsel, Cmte on Vet Affairs (04)
Covered position (LISA LAYMAN): SPA, Sen Stabenow(05-07)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Medicare Payment Advisory Commission (MedPAC)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MIRACA LIFE SCIENCES — Lobbying — Receipts Report